Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Clinical trial NCT00135577 · COMPLETED
Trial details
- NCT number
- NCT00135577
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2007-04-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.